Cemtrex (CETX) risk factors, FY2025 10-K

Risks Related to Macroeconomics Conditions and International Operations

1. 01Our operations and performance depend significantly on global and regional economic conditions and adverse economic conditions can materially adversely affect our business, results of operations and financial condition
2. 02Our business can be impacted by political events, trade and other international disputes, war, terrorism, natural disasters, public health issues, industrial accidents, and other business interruptions
3. 03Volatility in currency exchange rates may adversely affect our financial condition, results of operations and cash flows
4. 04Our business and results of operations may be materially adversely affected by compliance with import and export laws
5. 05Our international operations subject us to many different and complex laws and rules, and we may face difficulty in compliance

Risks Related to our Financial Condition

1. 06The report of our independent registered public accounting firm contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a going concern
2. 07The Company has incurred substantial losses of $28.3 million and $7.6 million for fiscal years 2025 and 2024, respectively, and working capital of $5.2 million as at the end of fiscal 2025, that raise substantial doubt with respect to the Company’s ability to continue as a going concern31% rewritten
3. 08There is no guarantee that cash flow from operations and/or debt and equity financings will provide sufficient capital to meet our expansion goals working capital needs or fund our operations
4. 09We have a history of losses and may experience losses in the future, which could result in the market price of our common stock declining26% rewritten
5. 10The Company is exposed to credit risk, market risk, and fluctuations in the value of its investment portfolio
6. 11We have substantial debt which could adversely affect our ability to raise additional capital to fund operations and prevent us from meeting our obligations under outstanding indebtedness25% rewritten
7. 12Our ability to secure and maintain sufficient credit arrangements is key to our continued operations and there is no assurance we will be able to obtain sufficient additional equity or debt financing in the future

Risks Related to Our Investment in Digital Assets

1. 13The value of our digital asset holdings is highly volatile and may decline significantlyNew
2. 14Our digital assets are subject to risks associated with staking and the Solana networkNew
3. 15Regulatory developments could adversely affect our digital asset holdingsNew
4. 16We face cybersecurity, custody, and theft risks with our digital assetsNew
5. 17Valuation, accounting, and liquidity risks associated with digital assets could impact our financial reportingNew
6. 18Our digital asset strategy may distract management or fail to deliver expected benefitsNew

Risks Related to our Business

1. 19We are substantially dependent upon the success and continued market acceptance of our technology, the absence of which may significantly reduce our sales, profits and cash flow and adversely impact our financial condition
2. 20Our future operating results depend in part on continued successful research, development and marketing of new and improved products and services through our Security segment, and there can be no assurance that we will successfully introduce new products and services into the market
3. 21Our future operating results depends in part on the continued successful operation of our Industrial Services segment, and there can be no assurance that we will be successful in this business
4. 22Our operating results may fluctuate, which could have a negative impact on our ability to grow our client base, establish sustainable revenues and succeed overall
5. 23We operate in a cyclical business, which could result in significant fluctuations in demand for our products
6. 24Our sales and gross margins depend significantly on market demand for our products, as to which there can be no assurance
7. 25Our products face intense competitive challenges, including rapid technological changes, and pricing pressure from competitors, which could adversely affect our business
8. 26Factors affecting the industries that utilize our products could negatively impact our customers and us
9. 27If we are unable to develop new products, our competitors may develop and market products with better features that may reduce demand for our existing and potential products or otherwise result in our products becoming obsolete and could materially and adversely affect our ability to sustain profitability
10. 28We are increasingly dependent on information technology, and if we are unable to protect against service interruptions, data corruption, cyber-based attacks, or network security breaches our operations could be disrupted, and we could incur significant costs and reputational harm as a result
11. 29Security breaches, denial of service attacks, or other hacking and phishing attacks on our systems or other security breaches, including internal security failures, could harm our reputation or subject us to significant liability, and adversely affect our business and financial results
12. 30Our operating results are sensitive to raw material and resale product availability, quality, and cost

Risks Related to Legal Uncertainty

1. 31We could be subject to additional civil penalties or face criminal penalties and sanctions if we violate the terms of settlement with the SEC
2. 32Provisions in the Delaware law and our Bylaws could make it very difficult for an investor to bring any legal actions against our directors or officers for violations of their fiduciary duties or could require us to pay any amounts incurred by our directors or officers in any such actions
3. 33If we fail to establish, maintain, and enforce intellectual property rights with respect to our technology, our financial condition, results of operations and business could be negatively impacted
4. 34We may not have sufficient financial resources to defend our intellectual property rights or otherwise successfully defend against claims that we have infringed on a third party’s intellectual property and, as a result, it may adversely affect our business, financial condition, and results of operations
5. 35Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of our product or any future products that we may develop

Risks Related to Acquisitions

1. 36We have grown through acquisitions and are continuously looking to fund other acquisitions; our failure to raise funds for acquisitions may have the effect of slowing down our growth and our use of funds for acquisitions subjects us to acquisition-related risks
2. 37We may fail to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions

Risks Related to Our Management and Control Persons

1. 38The loss of the services of Saagar Govil for any reason would materially and adversely affect our business operations and prospects
2. 39If we are unable to attract and retain qualified personnel, especially our design and technical personnel, we may not be able to execute our business strategy effectively
3. 40Our management stockholders have significant stockholdings in and influence over our company which could make it impossible for public stockholders to influence the affairs of our company
4. 41Liability of directors for breach of duty is limited under Delaware law
5. 42These limitations of liability do not apply to liabilities arising under the federal or state securities laws and do not affect the availability of equitable remedies such as injunctive relief or rescission
6. 43Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable

Risks Related to Our Securities and the Markets for Our Securities

1. 44Sales of substantial amounts of our securities in the public market could depress the market price of our common stock
2. 45Our securities may experience extreme price and volume fluctuations, which could lead to costly litigation for us and make an investment in us less appealing
3. 46We have issued Series A Warrants and Series B Warrants in connection with the public offering completed in May 2024 that have provisions that can increase the number of warrants and reduce the exercise price if we complete certain transactions31% rewritten
4. 47Further adjustments to the Series A Warrants and Series B Warrant exercise price and number of warrants may occur if we complete any additional transactions or complete another reverse stock split per the terms of the Series A Warrants and Series B Warrants
5. 48Provisions of the Series A Warrants and Series B Warrants could discourage an acquisition of us by a third-party
6. 49The Series A Warrants and Series B Warrants may have an adverse effect on the market price of our common stock and make it more difficult to effect a business combination
7. 50We will likely not receive any additional funds upon the exercise of the Series A Warrants
8. 51Our Series 1 preferred stock and all of our existing and future indebtedness rank senior to our common stock in the event of a liquidation, winding up or dissolution of our business28% rewritten
9. 52Our common stockholders may be adversely affected by the issuance of any subsequent series of preferred stock
10. 53The public trading market for the common stock may be limited in the future
11. 54We may not pay cash dividends on our common stock
12. 55If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline
13. 56If our shares become subject to the penny stock rules, it would become more difficult to trade our shares
14. 57FINRA sales practice requirements may limit a stockholder’s ability to buy and sell our securities
15. 58Future sales and issuances of our Common Stock or rights to purchase Common Stock, including pursuant to our equity incentive plans and outstanding options could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall
16. 59Although our Common Stock is listed on the Nasdaq Capital Market, the exchange may subsequently delist our Common Stock as it has with our Series 1 Preferred Stock if we fail to comply with ongoing listing standards
17. 60On October 23, 2024, the Company received a letter from Nasdaq that it had been granted an extension to regain compliance with the Minimum Stockholder’s Equity Requirement
18. 614. A disclosure stating that Nasdaq will continue to monitor the Company’s ongoing compliance with the stockholders’ equity requirement and, if at the time of its next periodic report the Company does not evidence compliance, that it may be subject to delisting
19. 62Regardless of which alternative the Company chooses, if the Company fails to evidence compliance upon filing its periodic report for the March 31, 2025, with the SEC and Nasdaq, the Company may be subject to delisting
20. 63Trading on the OTC Pink Market is volatile and sporadic, which could depress the market price of the Series 1 Preferred Stock and make it difficult for the holders to resell their Series 1 Preferred Stock